{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:58:21Z","timestamp":1740135501731,"version":"3.37.3"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008018","name":"Victorian Cancer Agency","doi-asserted-by":"publisher","award":["MCRF20029"],"award-info":[{"award-number":["MCRF20029"]}],"id":[{"id":"10.13039\/100008018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Urinary incontinence (UI) is the most prevalent pelvic floor disorder following treatment for gynaecological cancer with a distressing impact on quality-of-life in survivors. Physiotherapist-supervised pelvic floor muscle (PFM) training is recommended as the first-line intervention for UI in community-dwelling women. However, it is not known if this intervention is effective in women following treatment for gynaecological cancer, nor whether PFM training can be delivered entirely remotely. The primary aim of this study is to investigate if a telehealth-delivered PFM training program incorporating a novel biofeedback device reduces UI compared with usual care, following gynaecological cancer.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This is a pragmatic, two-arm parallel-group, stratified superiority randomised controlled trial recruiting 72 participants (ACTRN12622000580774). Recruitment sites include gynaecology-oncology outpatient clinics, supplemented by advertisements through community foundations\/social media\/care groups. Participants must have completed primary cancer treatment at least 6 months prior or adjuvant therapy at least 3 months prior, for Stage I, II or III uterine, cervical, fallopian tube, primary peritoneal or ovarian cancer or borderline ovarian tumour, and have UI occurring at least weekly. Participants randomised to the usual care group will receive bladder and bowel advice handouts and one audio telehealth physiotherapist consultation to answer any queries about the handouts. Participants randomised to the intervention group will receive the same handouts plus eight video telehealth physiotherapist consultations for PFM training with a biofeedback device (femfit<jats:sup>\u00ae<\/jats:sup>), alongside a home-based program over 16 weeks. The primary outcome measure is a patient-reported outcome of UI frequency, amount and interference with everyday life (measured using the International Consultation on Incontinence Questionnaire \u2013 Urinary Incontinence Short Form), immediately post-intervention compared with baseline. Secondary outcomes include quality-of-life measures, bother of pelvic floor symptoms, leakage episodes, use of continence pads and global impression of change. We will also investigate if the intervention improves intra-vaginal resting and squeeze pressure in women in the intervention arm, using data from the biofeedback device.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>If clinical effectiveness of telehealth-delivered physiotherapist-supervised PFM training, supplemented with home biofeedback is shown, this will allow this therapy to enter pathways of care, and provide an evidence-based option for treatment of post-cancer UI not currently available.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>Australian New Zealand Clinical Trials Registry (ANZCTR), ID 12622000580774. Registered 20 April 2022.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12905-024-03365-9","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T08:02:21Z","timestamp":1727424141000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Telehealth exercise for continence after gynaecological cancer treatment (TELE-CONNECT): a protocol for a co-designed pragmatic randomised controlled trial"],"prefix":"10.1186","volume":"24","author":[{"given":"Helena C","family":"Frawley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Bennell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel K.","family":"Nelligan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Ravi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nipuni","family":"Susanto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Hyde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orla","family":"McNally","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Ern","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen E","family":"Lamb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peixuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Denehy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the TELE-CONNECT study team","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Merolli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Jobling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Kruger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha","family":"Hickey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lesley","family":"McQuire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rowan","family":"Cockerell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,27]]},"reference":[{"key":"3365_CR1","unstructured":"Milsom I, Altman D, Cartwright R, Lapitan MC, Nelson R, Sjostrom S, et al. Epidemiology of urinary incontinence (UI) and and other lower urinary tract symtpoms (LUTS), pelvic organ prolapse (POP) and anal incontinence (AI). In: Cardozo LD, Rovner ES, Wagg A, Wein A, Abrams P, editors. 7th International Consultation. on Incontinence:\u00a0Bristol: ICUD ICS; 2023. p. 13\u2013130."},{"key":"3365_CR2","unstructured":"Continence Fondation of Australia. Continence in Australia a snapshot June 2019. https:\/\/www.continence.org.au\/news\/2019-continence-in-australia-snapshot-report."},{"issue":"1","key":"3365_CR3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/bju.12852","volume":"115","author":"P Abrams","year":"2015","unstructured":"Abrams P, Smith AP, Cotterill N. The impact of urinary incontinence on health-related quality of life (HRQoL) in a real-world population of women aged 45\u201360 years: results from a survey in France, Germany, the UK and the USA. BJU Int. 2015;115(1):143\u201352.","journal-title":"BJU Int"},{"issue":"4","key":"3365_CR4","first-page":"459","volume":"29","author":"AS Ramaseshan","year":"2018","unstructured":"Ramaseshan AS, Felton J, Roque D, Rao G, Shipper AG, Sanses TVD. Pelvic floor disorders in women with gynecologic malignancies: a systematic review. Int Urogynecol J. 2018;29(4):459\u201376.","journal-title":"Int Urogynecol J"},{"key":"3365_CR5","doi-asserted-by":"publisher","unstructured":"Brennen R, Lin KY, Denehy L, Soh SE, Jobling T, McNally OM et al. Natural history of pelvic floor disorders before and after hysterectomy for gynaecological cancer. BJOG. 2024. https:\/\/doi.org\/10.1111\/1471-0528.17870. Online ahead of print.","DOI":"10.1111\/1471-0528.17870"},{"issue":"3","key":"3365_CR6","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"3365_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41598-019-38759-5","volume":"9","author":"M Neron","year":"2019","unstructured":"Neron M, Bastide S, de Tayrac R, Masia F, Ferrer C, Labaki M, et al. Impact of gynecologic cancer on pelvic floor disorder symptoms and quality of life: an observational study. Sci Rep. 2019;9:9.","journal-title":"Sci Rep"},{"key":"3365_CR8","doi-asserted-by":"publisher","first-page":"101007","DOI":"10.1016\/j.gore.2022.101007","volume":"41","author":"R Brennen","year":"2022","unstructured":"Brennen R, Lin KY, Denehy L, Soh SE, Frawley H. Patient and clinician perspectives of pelvic floor dysfunction after gynaecological cancer. Gynecol Oncol Rep. 2022;41:101007.","journal-title":"Gynecol Oncol Rep"},{"key":"3365_CR9","doi-asserted-by":"publisher","unstructured":"Dumoulin C, Cacciari LP, Hay-Smith EJC. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database Syst Rev.\u00a02018;10(10):CD005654. https:\/\/doi.org\/10.1002\/14651858.CD005654.pub4.","DOI":"10.1002\/14651858.CD005654.pub4"},{"key":"3365_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jphys.2020.06.011","author":"K B\u00f8","year":"2020","unstructured":"B\u00f8 K. Physiotherapy management of urinary incontinence in females. J Physiother. 2020. https:\/\/doi.org\/10.1016\/j.jphys.2020.06.011. in press.","journal-title":"J Physiother"},{"issue":"10","key":"3365_CR11","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1034\/j.1600-0412.2003.00177.x","volume":"82","author":"T-Y Chuang","year":"2003","unstructured":"Chuang T-Y, Yu K-J, Penn I-W, Chang Y-C, Lin P-H, Tsai Y-A. Neurourological changes before and after radical hysterectomy in patients with cervical cancer. Acta Obstet Gynecol Scand. 2003;82(10):954\u20139.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"2","key":"3365_CR12","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s11764-015-0481-8","volume":"10","author":"S Bernard","year":"2016","unstructured":"Bernard S, Ouellet MP, Moffet H, Roy JS, Dumoulin C. Effects of radiation therapy on the structure and function of the pelvic floor muscles of patients with cancer in the pelvic area: a systematic review. J Cancer Surviv. 2016;10(2):351\u201362.","journal-title":"J Cancer Surviv"},{"issue":"4","key":"3365_CR13","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1093\/ptj\/pzx012","volume":"97","author":"S Bernard","year":"2017","unstructured":"Bernard S, Moffet H, Plante M, Ouellet MP, Leblond J, Dumoulin C. Pelvic-floor properties in Women reporting urinary incontinence after surgery and radiotherapy for endometrial cancer. Phys Ther. 2017;97(4):438\u201348.","journal-title":"Phys Ther"},{"issue":"8","key":"3365_CR14","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1093\/ptj\/pzaa081","volume":"100","author":"R Brennen","year":"2020","unstructured":"Brennen R, Lin K, Denehy L, Frawley H. The effect of pelvic floor muscle interventions on pelvic floor dysfunction after gynaecological cancer treatment: a systematic review. Phys Ther. 2020;100(8):1357\u201371.","journal-title":"Phys Ther"},{"key":"3365_CR15","doi-asserted-by":"publisher","unstructured":"Cyr MP, Brennen R, Colombage U, Jones T, Frawley HC. Effectiveness of pelvic floor muscle therapies and education-based interventions on bladder, bowel, vaginal, sexual, psychological function, quality of life, and pelvic floor muscle function in females treated for gynecological cancer: a systematic review. Curr Oncol Rep. 2024; accepted. https:\/\/doi.org\/10.1007\/s11912-024-01586-7.","DOI":"10.1007\/s11912-024-01586-7"},{"key":"3365_CR16","volume-title":"National framework for gynaecological cancer control","author":"Cancer Australia","year":"2016","unstructured":"Cancer Australia. National framework for gynaecological cancer control. Surry Hills: Cancer Australia; 2016."},{"issue":"1","key":"3365_CR17","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12905-020-01012-7","volume":"20","author":"N Nakayama","year":"2020","unstructured":"Nakayama N, Tsuji T, Aoyama M, Fujino T, Liu MG. Quality of life and the prevalence of urinary incontinence after surgical treatment for gynecologic cancer: a questionnaire survey. BMC Womens Health. 2020;20(1):148. https:\/\/doi.org\/10.1186\/s12905-020-01012-7.","journal-title":"BMC Womens Health."},{"issue":"1","key":"3365_CR18","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00520-016-3394-9","volume":"25","author":"A Lindgren","year":"2017","unstructured":"Lindgren A, Dunberger G, Enblom A. Experiences of incontinence and pelvic floor muscle training after gynaecologic cancer treatment. Support Care Cancer. 2017;25(1):157\u201366.","journal-title":"Support Care Cancer"},{"key":"3365_CR19","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1007\/s00192-020-04340-2","volume":"31","author":"ZH Huang","year":"2020","unstructured":"Huang ZH, Wu SY, Yu T, Hu AL. Efficacy of telemedicine for urinary incontinence in women: a systematic review and meta-analysis of randomized controlled trials. Int Urogynecol J. 2020;31:1507\u201313.","journal-title":"Int Urogynecol J"},{"issue":"2","key":"3365_CR20","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s00192-020-04588-8","volume":"32","author":"KRU da Mata","year":"2021","unstructured":"da Mata KRU, Costa RCM, Carbone \u00c9DSM, Gimenez MM, Bortolini MAT, Castro RA, et al. Telehealth in the rehabilitation of female pelvic floor dysfunction: a systematic literature review. Int Urogynecol J. 2021;32(2):249\u201359.","journal-title":"Int Urogynecol J"},{"key":"3365_CR21","doi-asserted-by":"publisher","DOI":"10.2196\/44929","volume":"11","author":"SJ Woodley","year":"2023","unstructured":"Woodley SJ, Moller B, Clark AR, Bussey MD, Sangelaji B, Perry M, et al. Digital Technologies for women\u2019s pelvic floor muscle training to manage urinary incontinence across their life course: scoping review. JMIR Mhealth Uhealth. 2023;11: e44929.","journal-title":"JMIR Mhealth Uhealth"},{"issue":"10","key":"3365_CR22","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00520-023-08050-5","volume":"31","author":"R Brennen","year":"2023","unstructured":"Brennen R, Soh SE, Denehy L, Lin KY, Jobling T, McNally OM, et al. Pelvic floor muscle training delivered via telehealth to treat urinary and\/or faecal incontinence after gynaecological cancer surgery: a single cohort feasibility study. Support Care Cancer. 2023;31(10):589.","journal-title":"Support Care Cancer"},{"issue":"5","key":"3365_CR23","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1056\/NEJMra1510059","volume":"375","author":"I Ford","year":"2016","unstructured":"Ford I, Norrie J, Pragmatic Trials. N Engl J Med. 2016;375(5):454\u201363.","journal-title":"N Engl J Med"},{"key":"3365_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.a2390","volume":"337","author":"M Zwarenstein","year":"2008","unstructured":"Zwarenstein M, Treweek S, Gagnier JJ, Altman DG, Tunis S, Haynes B, et al. Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ. 2008;337: a2390.","journal-title":"BMJ"},{"issue":"1","key":"3365_CR25","doi-asserted-by":"publisher","first-page":"40","DOI":"10.7326\/M17-0046","volume":"167","author":"I Boutron","year":"2017","unstructured":"Boutron I, Altman DG, Moher D, Schulz KF, Ravaud P. CONSORT statement for randomized trials of nonpharmacologic treatments: a 2017 update and a CONSORT extension for nonpharmacologic trial abstracts. Ann Intern Med. 2017;167(1):40\u20137.","journal-title":"Ann Intern Med"},{"key":"3365_CR26","doi-asserted-by":"publisher","first-page":"c869","DOI":"10.1136\/bmj.c869","volume":"340","author":"D Moher","year":"2010","unstructured":"Moher D, Hopewell S, Schulz KF, Montori V, G\u00f8tzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869.","journal-title":"BMJ"},{"key":"3365_CR27","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.physio.2021.03.001","volume":"112","author":"SC Slade","year":"2021","unstructured":"Slade SC, Morris ME, Frawley H, Hay-Smith J. Comprehensive reporting of pelvic floor muscle training for urinary incontinence: CERT-PFMT. Physiotherapy. 2021;112:103\u201312.","journal-title":"Physiotherapy"},{"key":"3365_CR28","unstructured":"Therapeutic Goods Administration. The Australian Register of therapeutic goods. Junofem femfit JFF-003 - Perineometer: https:\/\/www.tga.gov.au\/resources\/artg\/345787."},{"issue":"1","key":"3365_CR29","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/nau.24179","volume":"39","author":"LP Cacciari","year":"2020","unstructured":"Cacciari LP, Kruger J, Goodman J, Budgett D, Dumoulin C. Reliability and validity of intravaginal pressure measurements with a new intravaginal pressure device: the FemFit (R). Neurourol Urodyn. 2020;39(1):253\u201360.","journal-title":"Neurourol Urodyn"},{"issue":"6","key":"3365_CR30","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1080\/09593985.2017.1419520","volume":"34","author":"ECL Mateus-Vasconcelos","year":"2018","unstructured":"Mateus-Vasconcelos ECL, Ribeiro AM, Antonio FI, Brito LGD, Ferreira CHJ. Physiotherapy methods to facilitate pelvic floor muscle contraction: a systematic review. Physiother Theory Pract. 2018;34(6):420\u201332.","journal-title":"Physiother Theory Pract"},{"issue":"8","key":"3365_CR31","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1097\/PHM.0b013e31824ad462","volume":"91","author":"MW Hildebrand","year":"2012","unstructured":"Hildebrand MW, Host HH, Binder EF, Carpenter B, Freedland KE, Morrow-Howell N, et al. Measuring treatment fidelity in a rehabilitation intervention study. Am J Phys Med Rehabil. 2012;91(8):715\u201324.","journal-title":"Am J Phys Med Rehabil"},{"issue":"4","key":"3365_CR32","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/nau.20041","volume":"23","author":"K Avery","year":"2004","unstructured":"Avery K, Donovan J, Peters TJ, Shaw C, Gotoh M, Abrams P. ICIQ: a brief and robust measure for evaluating the symptoms and impact of urinary incontinence. Neurourol Urodyn. 2004;23(4):322\u201330.","journal-title":"Neurourol Urodyn"},{"key":"3365_CR33","unstructured":"Castro-Diaz D, Robinson D, Arlandis G, Bosch J, Costantini E, Cotterill N, et al. Patient reported outcome assessment. In: Cardozo L, Rovner ES, Wagg A, Wein A, Abrams P, editors. Incontinence. 7th ed.\u00a0Bristol: ICUD; 2023."},{"issue":"8","key":"3365_CR34","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/nau.22657","volume":"34","author":"E Nystrom","year":"2015","unstructured":"Nystrom E, Sjostrom M, Stenlund H, Samuelsson E. ICIQ symptom and quality of life instruments measure clinically relevant improvements in women with stress urinary incontinence. Neurourol Urodyn. 2015;34(8):747\u201351.","journal-title":"Neurourol Urodyn"},{"issue":"12","key":"3365_CR35","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1111\/j.1471-0528.1997.tb11006.x","volume":"104","author":"CJ Kelleher","year":"1997","unstructured":"Kelleher CJ, Cardozo LD, Khullar V, Salvatore S. A new questionnaire to assess the quality of life of urinary incontinent women. Br J Obstet Gynaecol. 1997;104(12):1374\u20139.","journal-title":"Br J Obstet Gynaecol"},{"issue":"9","key":"3365_CR36","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1007\/s00192-010-1148-7","volume":"21","author":"TV Peterson","year":"2010","unstructured":"Peterson TV, Karp DR, Aguilar VC, Davila GW. Validation of a global pelvic floor symptom bother questionnaire. Int Urogynecol J. 2010;21(9):1129\u201335.","journal-title":"Int Urogynecol J"},{"issue":"1","key":"3365_CR37","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2307\/41410412","volume":"36","author":"V Venkatesh","year":"2012","unstructured":"Venkatesh V, Thong JYL, Xu X. Consumer acceptance and use of information technology: extending the unified theory of acceptance and use of technology. Mi Q. 2012;36(1):157\u201378.","journal-title":"Mi Q"},{"issue":"5","key":"3365_CR38","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/nau.20243","volume":"25","author":"KL Burgio","year":"2006","unstructured":"Burgio KL. Global ratings of patient satisfaction and perceptions of improvement with treatment for urinary incontinence: validation of three global patient ratings. Neurourol Urodyn. 2006;25(5):411\u20137.","journal-title":"Neurourol Urodyn"},{"issue":"7","key":"3365_CR39","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1249\/01.mss.0000227310.18902.28","volume":"38","author":"U M\u00e4der","year":"2006","unstructured":"M\u00e4der U, Martin BW, Schutz Y, Marti B. Validity of four short physical activity questionnaires in middle-aged persons. Med Sci Sports Exerc. 2006;38(7):1255\u201366.","journal-title":"Med Sci Sports Exerc"},{"key":"3365_CR40","unstructured":"National Health and Medical Research Council. Safety monitoring and reporting in clinical trials involving therapeutic goods. In: Australian Government Department of Health. 2016. https:\/\/www.nhmrc.gov.au\/about-us\/publications\/safety-monitoring-and-reporting-clinical-trials-involving-therapeutic-goods."},{"key":"3365_CR41","unstructured":"National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0. 2017. https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/docs\/CTCAE_v5_Quick_Reference_5x7.pdf."},{"key":"3365_CR42","volume-title":"NCI Guidelines for Investigators: Adverse Event Reporting Requirements for DCTD (CTEP and CIP) and DCP INDs and IDEs","author":"Institute NC","year":"2013","unstructured":"Institute NC. NCI Guidelines for Investigators: Adverse Event Reporting Requirements for DCTD (CTEP and CIP) and DCP INDs and IDEs. 2013."},{"issue":"5","key":"3365_CR43","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1080\/00273171.2017.1344538","volume":"52","author":"D McNeish","year":"2017","unstructured":"McNeish D. Small sample methods for Multilevel modeling: a colloquial elucidation of REML and the Kenward-Roger correction. Multivar Behav Res. 2017;52(5):661\u201370.","journal-title":"Multivar Behav Res"},{"issue":"8","key":"3365_CR44","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1093\/ptj\/83.8.713","volume":"83","author":"CG Maher","year":"2003","unstructured":"Maher CG, Sherrington C, Herbert RD, Moseley AM, Elkins M. Reliability of the PEDro scale for rating quality of randomized controlled trials. Phys Ther. 2003;83(8):713\u201321.","journal-title":"Phys Ther"},{"issue":"1","key":"3365_CR45","first-page":"134","volume":"62","author":"K-Y Liang","year":"2000","unstructured":"Liang K-Y, Zeger SL. Longitudinal data analysis of continuous and discrete responses for pre-post designs. Sankhy\u0101: Indian J Stat Ser B (1960\u20132002). 2000;62(1):134\u201348.","journal-title":"Sankhy\u0101: Indian J Stat Ser B (1960\u20132002)"},{"issue":"434","key":"3365_CR46","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1080\/01621459.1996.10476902","volume":"91","author":"JD Angrist","year":"1996","unstructured":"Angrist JD, Imbens GW, Rubin DB. Identification of causal effects using instrumental variables. J Am Stat Assoc. 1996;91(434):444\u201355.","journal-title":"J Am Stat Assoc"},{"issue":"11","key":"3365_CR47","first-page":"673","volume":"10","author":"MY Bertram","year":"2021","unstructured":"Bertram MY, Lauer JA, Stenberg K, Edejer TTT. Methods for the economic evaluation of health care interventions for priority setting in the health system: an update from WHO choice. Int J Health Policy Manag. 2021;10(11):673\u20137.","journal-title":"Int J Health Policy Manag"},{"issue":"5","key":"3365_CR48","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3109\/07853890109002087","volume":"33","author":"R Rabin","year":"2001","unstructured":"Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001;33(5):337\u201343.","journal-title":"Ann Med"},{"key":"3365_CR49","volume-title":"EQ-5D-5L User Guide","author":"Euroqol","year":"2019","unstructured":"Euroqol. EQ-5D-5L User Guide. 2019."}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-024-03365-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-024-03365-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-024-03365-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T08:02:29Z","timestamp":1727424149000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-024-03365-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,27]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3365"],"URL":"https:\/\/doi.org\/10.1186\/s12905-024-03365-9","relation":{},"ISSN":["1472-6874"],"issn-type":[{"type":"electronic","value":"1472-6874"}],"subject":[],"published":{"date-parts":[[2024,9,27]]},"assertion":[{"value":"13 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study will be conducted according to the principles of the Declaration of Helsinki and in accordance with the ICH-GCP guidelines and the local regulations. This study protocol and the master informed consent form have been approved by the Monash Health Human Research Ethics Committee. The study was first registered on 20.04.2022 in the Australian New Zealand Clinical Trials Registry (ANZCTR): ACTRN12622000580774. If a patient agrees to participate in the study, written informed consent will be obtained after which participants will complete baseline assessment and then be randomly allocated to the intervention group or control group. Any modifications to the protocol which may impact on the conduct of the study, potential benefit of the patient or may affect patient safety, including changes of study objectives, study design, patient population, sample sizes, study procedures, or significant administrative aspects will require a formal amendment to the protocol. Such amendments will be agreed upon by the project group and approved by Monash Health HREC prior to implementation and notified to the participating sites in accordance with local regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"529"}}